1 results match your criteria: "Department of Hematology Kokura Memorial Hospital Kitakyushu Japan.[Affiliation]"
Article Synopsis
- Nilotinib is a type of medication used to block a specific protein (BCR-ABL) involved in cancer, but it also affects how other drugs are metabolized in the body by inhibiting the enzyme CYP3A4.
- Because it can raise the levels of other drugs that are processed by CYP3A4, healthcare providers need to be cautious when prescribing these medications to patients taking nilotinib.
- After a transplant, patients treated with nilotinib require close monitoring of their drug levels to ensure safe and effective use of immunosuppressive medications.